Skip to content

Blood Transfusions in Preterm Infants

Effect of Blood Transfusions on the Outcome of Low Birth Weight Preterm Infants

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05331235
Enrollment
40
Registered
2022-04-15
Start date
2022-05-01
Completion date
2023-01-01
Last updated
2022-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm, Red Blood Cells

Brief summary

A cross sectional study to assess the effect of blood transfusions on the outcome of preterm infants

Detailed description

This is a cross sectional study carried on preterm infants who are staying in the hospital as growers; to gain weight. We will assess blood transfusion received by these preterm infants in details.

Interventions

None listed

Sponsors

Kasr El Aini Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Grower preterm infants

Exclusion criteria

* Severe illness, Hypovolemic shock, Hypoxia, Oxygen therapy, Surgical intervention

Design outcomes

Primary

MeasureTime frameDescription
Change in heart rateimmediately before and immediately after blood transfusionHeart rate per minute
Change in respiratory rateimmediately before and immediately after blood transfusionRespiratory rate per minute
Change in weight gainwithin 4 days before and within 4 days after blood transfusionAverage weight gain in grams/kg/day
Change in hemoglobinimmediately before and immediately after blood transfusionHemoglobin in grams/dl
Change in hematocrit valueimmediately before and immediately after blood transfusionHematocrit value percentage

Secondary

MeasureTime frameDescription
Tachypneain the previous 24 hours before blood transfusion≥24 hours of tachypnea (Respiratory rate\>60/minute),
Poor weight gainin the previous 4 days before blood transfusion≤10 g/kg/day while the infant is receiving ≥120 kcal/kg/day
Metabolic acidosisin the previous 24 hours before blood transfusionpH \<7.2
Acute blood lossin the previous 24 hours before blood transfusionAcute blood loss either spontaneous or iatrogenic during invasive procedures
Length of stay in the NICUfrom date of birth until the date of transfer to the grower ward or date of death from any cause, whichever came first, assessed up to 3 months.Length of stay in the NICU
Length of stay in the hospitalfrom date of birth until the date of discharge home or date of death from any cause, whichever came first, assessed up to 3 months.Length of stay in the hospital
Mortalityfrom the date of transfer to grower ward, assessed up to 3 months.Death
Apnea and bradycardiain the previous 24 hours before blood transfusion9 episodes or ≥2 episodes requiring bag and mask ventilation, while infant is receiving caffeine citrate
Mechanical ventilationin the previous 24 hours before blood transfusionMechanical ventilation (MV) which may be one of two possibilities: 1. Moderate or significant MV; Mean airway pressure (MAP) \>8 cm H2O on conventional ventilator or \>14 cm H2O on high frequency ventilator and FiO2 \>0.4 2. Minimal MV; MAP ≤8 cmH2O on conventional ventilator or ≤14 cm H2O on high frequency ventilator and FiO2 ≤ 0.4
Supplemental oxygenin the previous 24 hours before blood transfusionSupplemental oxygen, not mechanically ventilated
Doubling of oxygen requirementsin the previous 2 days before blood transfusionDoubling of oxygen requirements for patients on supplemental oxygen
Tachycardiain the previous 24 hours before blood transfusion≥24 hours of tachycardia (Heart rate\>180/minute)

Contacts

Primary ContactDouaa El Sherbiny, MD
doaa.sherbiny@gmail.com01000039725

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026